PHENYLBUTAZONE AND ISONIAZID METABOLISM IN PATIENTS WITH LIVER DISEASE IN RELATION TO PREVIOUS DRUG THERAPY
- 1 June 1968
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 291 (7555), 1275-1279
- https://doi.org/10.1016/s0140-6736(68)92292-7
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- RATE OF METABOLISM OF TOLBUTAMIDE IN TEST SUBJECTS WITH LIVER DISEASE OR WITH IMPAIRED RENAL FUNCTIONThe American Journal of the Medical Sciences, 1964
- The Metabolism of Tritiated Digoxin in Cirrhotic PatientsGastroenterology, 1964
- Disappearance Rate of Tolbutamide in Normal Subjects and in Diabetes Mellitus, Liver Cirrhosis, and Renal DiseaseDiabetes, 1963
- Morphine tolerance in hepatic cirrhosisGastroenterology, 1961
- PERSISTENCE OF ANTIBIOTICS IN BLOOD OF PATIENTS WITH ACUTE RENAL FAILURE. II. CHLORAMPHENICOL AND ITS METABOLIC PRODUCTS IN THE BLOOD OF PATIENTS WITH SEVERE RENAL DISEASE OR HEPATIC CIRRHOSIS*†JCI Insight, 1959
- Imperfection: Biochemical Phobias and Metabolic AmbivalencePerspectives in Biology and Medicine, 1959
- THE EFFECT OF BARBITURATES IN PATIENTS WITH LIVER DISEASE 1JCI Insight, 1954
- OBSERVATIONS ON THE METABOLIC TRANSFORMATION AND EFFECTS OF PHENYLBUTAZONE IN SUBJECTS WITH HEPATIC DISEASEThe American Journal of the Medical Sciences, 1954
- STUDIES OF THE LIVER FUNCTION OF DOGSAmerican Journal of Physiology-Legacy Content, 1932
- STUDIES ON THE PHYSIOLOGY OF THE LIVERAmerican Journal of Physiology-Legacy Content, 1931